| Recruiting | OURA Ring Wearable Testing in MDS Patients: a Feasibility and Discovery Pilot Study NCT06270771 | Sunnybrook Health Sciences Centre | — |
| Unknown | Clinical Study of Venetoclax Combined With Azacytiside in the Treatment of Myelodysplastic/Myeloproliferative NCT05282719 | The First Affiliated Hospital of Soochow University | Phase 2 |
| Completed | Prolonged or Standard Infusion of Cefepime Hydrochloride in Treating Patients With Febrile Neutropenia NCT01484015 | Wake Forest University Health Sciences | Phase 1 |
| Terminated | Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Malignancies or Secondary Myelodyspl NCT01118013 | Alliance for Clinical Trials in Oncology | Phase 2 |
| Completed | INCB18424 in Treating Young Patients With Relapsed or Refractory Solid Tumor, Leukemia, or Myeloproliferative NCT01164163 | Children's Oncology Group | Phase 1 |
| Terminated | Sirolimus, Tacrolimus, Thymoglobulin and Rituximab as Graft-versus-Host-Disease Prophylaxis in Patients Underg NCT01116232 | Barbara Ann Karmanos Cancer Institute | Phase 2 |
| Terminated | Lactobacillus in Preventing Infection in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Canc NCT00946283 | Rutgers, The State University of New Jersey | N/A |
| Terminated | Presence of Donor-Derived DNA in Semen Samples From Cancer Survivors Who Underwent Donor Stem Cell Transplant NCT01077440 | Vanderbilt University | — |
| Completed | Sorafenib in Combination With Cytarabine and Clofarabine in Patients With Refractory or Relapsed Hematologic M NCT00908167 | St. Jude Children's Research Hospital | Phase 1 |
| Recruiting | Registry of Older Patients With Cancer NCT01137825 | UNC Lineberger Comprehensive Cancer Center | — |
| Recruiting | 3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer NCT00935090 | Barbara Ann Karmanos Cancer Institute | — |
| Recruiting | Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer NCT01137643 | UNC Lineberger Comprehensive Cancer Center | — |
| Terminated | Methadone, Morphine, or Oxycodone in Treating Pain in Patients With Cancer NCT00726830 | M.D. Anderson Cancer Center | N/A |
| Completed | Donor Natural Killer Cells After Donor Stem Cell Transplant in Treating Patients With Advanced Cancer NCT00823524 | Asan Medical Center | Phase 1 / Phase 2 |
| Completed | Methemoglobinemia in Young Patients With Hematologic Cancer or Aplastic Anemia Treated With Dapsone NCT00993694 | Vanderbilt University | — |
| Terminated | Influenza Vaccine in Preventing Flu in Patients Who Have Undergone Stem Cell Transplant and in Healthy Volunte NCT00952185 | City of Hope Medical Center | N/A |
| Terminated | Total Marrow and Total Lymph Node Irradiation, Fludarabine, and Melphalan Followed By Donor Stem Cell Transpla NCT00800150 | City of Hope Medical Center | Phase 1 |
| Completed | Cyclosporine Eye Drops in Preventing Graft-Versus-Host Disease of the Eye in Patients Who Have Undergone Donor NCT00755040 | Vanderbilt-Ingram Cancer Center | Phase 3 |
| Completed | American Ginseng in Treating Patients With Fatigue Caused by Cancer NCT00719563 | Alliance for Clinical Trials in Oncology | Phase 3 |
| Terminated | Blood Samples From Patients on a Clinical Trial to CINV During HSCT NCT00900068 | OHSU Knight Cancer Institute | — |
| Completed | A Web-Based Stem Cell Transplant Support System or Standard Care in Young Patients Undergoing Stem Cell Transp NCT00782145 | Tufts Medical Center | Phase 3 |
| Completed | Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients With Hem NCT00691015 | Barbara Ann Karmanos Cancer Institute | Phase 2 |
| Withdrawn | Perceptions of Burden in Patients With Late-Stage Cancer and Their Caregivers NCT00770419 | Rutgers, The State University of New Jersey | — |
| Completed | Azacytidine and Bortezomib in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodys NCT00624936 | Ohio State University Comprehensive Cancer Center | Phase 1 |
| Completed | Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clin NCT00750009 | Case Comprehensive Cancer Center | Phase 3 |
| Completed | Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in NCT00516503 | Alliance for Clinical Trials in Oncology | Phase 3 |
| Completed | Rasburicase in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer or Other Disease Under NCT00513474 | Massachusetts General Hospital | Phase 1 |
| Completed | Selumetinib in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia NCT00588809 | National Cancer Institute (NCI) | Phase 2 |
| Terminated | Studying Fentanyl in Patients With Cancer NCT00899951 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | — |
| Completed | Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients Undergoi NCT00589563 | City of Hope Medical Center | Phase 2 |
| Completed | Fludarabine, Busulfan, and Antilymphocyte Globulin Followed by Donor Stem Cell Transplant in Treating Older Pa NCT00806767 | Institut Paoli-Calmettes | Phase 2 |
| Completed | Collecting and Storing Tissue and DNA Samples From Patients Undergoing a Donor Stem Cell Transplant NCT00900406 | Vanderbilt-Ingram Cancer Center | — |
| Completed | Flu Vaccine in Preventing Influenza Infection in Healthy Volunteers and in Patients Who Have Undergone Stem Ce NCT00964821 | City of Hope Medical Center | — |
| Terminated | T Cells in Predicting Acute Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant NCT00651716 | Vanderbilt-Ingram Cancer Center | — |
| Completed | Reduced-Intensity Regimen Before Donor Bone Marrow Transplant in Treating Patients With Myelodysplastic Syndro NCT00045305 | Eastern Cooperative Oncology Group | Phase 2 |
| Completed | Music in Reducing Anxiety and Pain in Adult Patients Undergoing Bone Marrow Biopsy for Hematologic Cancers or NCT00376922 | Wake Forest University Health Sciences | N/A |
| Withdrawn | Alemtuzumab Plus Fludarabine and Melphalan With or Without Cyclosporine, Mycophenolate Mofetil, and Low-Dose T NCT00085449 | Alliance for Clinical Trials in Oncology | Phase 1 / Phase 2 |
| Terminated | Moxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell Transplant NCT00324324 | OHSU Knight Cancer Institute | Phase 3 |
| Terminated | Donor Stem Cell Transplant or Donor White Blood Cell Infusions in Treating Patients With Hematologic Cancer NCT00281879 | OHSU Knight Cancer Institute | Phase 2 |
| Completed | 7-Hydroxystaurosporine and Perifosine in Treating Patients With Relapsed or Refractory Acute Leukemia, Chronic NCT00301938 | National Cancer Institute (NCI) | Phase 1 |
| Completed | VNP40101M in Treating Patients With Acute Myelogenous Leukemia or High-Risk Myelodysplasia NCT00083187 | Vion Pharmaceuticals | Phase 2 |
| Completed | A Standardized Nursing Intervention Protocol for HCT Patients NCT00951626 | City of Hope Medical Center | N/A |
| Unknown | Early Diagnosis of Aspergillosis in Patients at High Risk of Fungal Infection Caused by Treatment for Hematolo NCT00462657 | St. Bartholomew's Hospital | N/A |
| Completed | Busulfan, Fludarabine, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Tr NCT00245037 | OHSU Knight Cancer Institute | Phase 1 / Phase 2 |
| Unknown | Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer, Metastatic Kidney Cancer, or Aplastic NCT00295997 | University of California, San Francisco | N/A |
| Completed | Decitabine and FR901228 in Treating Patients With Relapsed or Refractory Leukemia, Myelodysplastic Syndromes, NCT00114257 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer Pain NCT00666211 | Vanderbilt-Ingram Cancer Center | Phase 3 |
| Completed | Alemtuzumab and Combination Chemotherapy Followed By Donor Lymphocytes in Treating Patients Who Are Undergoing NCT00104975 | Yale University | Phase 1 |
| Completed | Amifostine in Treating Young Patients With Newly Diagnosed De Novo Myelodysplastic Syndromes NCT00098683 | Children's Oncology Group | Phase 2 |
| Terminated | Arsenic Trioxide and Cholecalciferol (Vitamin D) in Treating Patients With Myelodysplastic Syndromes NCT00104806 | Wake Forest University Health Sciences | Phase 2 |
| Completed | Aprepitant, Granisetron, & Dexamethasone in Preventing Nausea & Vomiting in Pts. Receiving Cyclophosphamide Be NCT00293384 | Barbara Ann Karmanos Cancer Institute | N/A |
| Withdrawn | Collecting and Storing Blood Samples From Patients With Cancer NCT00900120 | University of Medicine and Dentistry of New Jersey | — |
| Completed | T-Cell-Depleted Allogeneic Stem Cell Transplantation After Immunoablative Induction Chemotherapy and Reduced-I NCT00080925 | National Institutes of Health Clinical Center (CC) | Phase 1 |
| Completed | Vatalanib in Treating Patients With Primary or Secondary Myelodysplastic Syndromes NCT00072475 | Alliance for Clinical Trials in Oncology | Phase 2 |
| Terminated | Fludarabine, Cyclophosphamide, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil i NCT00255684 | University of Rochester | N/A |
| Completed | Cholecalciferol in Treating Patients With Myelodysplastic Syndrome NCT00068276 | Wake Forest University Health Sciences | Phase 2 |
| Completed | Voriconazole in Preventing Fungal Infections in Children With Neutropenia After Chemotherapy NCT00066599 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Ravuconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Stem Cell Transplantation NCT00064311 | National Institutes of Health Clinical Center (CC) | Phase 1 / Phase 2 |
| Completed | 3-AP and Cytarabine in Treating Patients With Hematologic Cancer NCT00064090 | Vion Pharmaceuticals | Phase 1 |
| Completed | Donor Stem Cell Transplant After Busulfan, Fludarabine, and Antithymocyte Globulin in Treating Patients With H NCT00627666 | Asan Medical Center | Phase 2 |
| Completed | Sargramostim in Reducing Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplantat NCT00053157 | Roswell Park Cancer Institute | N/A |
| Unknown | Low-Dose Decitabine Compared With Standard Supportive Care in Treating Older Patients With Myelodysplastic Syn NCT00043134 | European Organisation for Research and Treatment of Cancer - EORTC | Phase 3 |
| Completed | FR901228 in Treating Patients With Myelodysplastic Syndrome, Acute Myeloid Leukemia, or Non-Hodgkin's Lymphoma NCT00042822 | Memorial Sloan Kettering Cancer Center | Phase 2 |
| Completed | VNP40101M in Treating Patients With Relapsed or Refractory Leukemia or Myelodysplastic Syndrome NCT00049686 | Vion Pharmaceuticals | Phase 1 |
| Terminated | Moxifloxacin Compared With Ciprofloxacin/Amoxicillin in Treating Fever and Neutropenia in Patients With Cancer NCT00062231 | European Organisation for Research and Treatment of Cancer - EORTC | N/A |
| Unknown | Light-Emitting Diode Therapy in Preventing Mucositis in Children Receiving Chemotherapy With or Without Radiat NCT00036712 | Medical College of Wisconsin | Phase 2 |
| Completed | Thalidomide in Treating Anemia in Patients With Myelodysplastic Syndrome NCT00030550 | Roswell Park Cancer Institute | Phase 2 |
| Completed | Total-Body Irradiation and Chemotherapy Followed By Donor Bone Marrow Transplant in Treating Young Patients Wi NCT00028730 | Memorial Sloan Kettering Cancer Center | Phase 2 |
| Completed | Bevacizumab in Treating Patients With Myelodysplastic Syndrome NCT00022048 | Stanford University | Phase 1 / Phase 2 |
| Completed | Melphalan, Fludarabine, and Alemtuzumab Followed by Peripheral Stem Cell Transplant in Treating Patients With NCT00027560 | Memorial Sloan Kettering Cancer Center | Phase 2 |
| Completed | Thalidomide and Epoetin Alfa in Treating Anemia in Patients With Myelodysplastic Syndrome NCT00053001 | Fallon Clinic | Phase 2 |
| Terminated | Arsenic Trioxide in Treating Patients With Myelodysplastic Syndromes NCT00020969 | CTI BioPharma | Phase 2 |
| Completed | Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Advanced Hematologi NCT00014469 | Memorial Sloan Kettering Cancer Center | Phase 2 |
| Completed | Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Advanced Myeloid Cancer NCT00014495 | Memorial Sloan Kettering Cancer Center | Phase 1 / Phase 2 |
| Completed | Radiolabeled Monoclonal Antibody Therapy and Etoposide Followed by Peripheral Stem Cell Transplantation in Tre NCT00006040 | Memorial Sloan Kettering Cancer Center | Phase 1 |
| Completed | Measuring Changes in Blood in Patients at High Risk of Cytomegalovirus Infection After Undergoing Donor Bone M NCT00716911 | City of Hope Medical Center | N/A |
| Completed | Sodium Salicylate in Treating Patients With Advanced Myelodysplastic Syndrome, Acute Myelogenous Leukemia, or NCT00004245 | Memorial Sloan Kettering Cancer Center | Phase 1 |
| Completed | Perifosine in Treating Patients With Refractory Solid Tumors or Hematologic Cancer NCT00019656 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Chemotherapy in Treating Children With Down Syndrome and Myeloproliferative Disorder, Acute Myelogenous Leukem NCT00003593 | Children's Oncology Group | Phase 3 |
| Completed | S9910, Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer NCT00919425 | SWOG Cancer Research Network | — |
| Completed | Intensive Compared With Nonintensive Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia or My NCT00005823 | Leukemia Research Fund | Phase 3 |
| Completed | Combination Chemotherapy With or Without Filgrastim and/or Tretinoin in Treating Patients With Acute Myeloid L NCT00005863 | Medical Research Council | Phase 3 |
| Unknown | Donor Stem Cell Transplant With or Without Chemotherapy in Treating Children With Primary Myelodysplastic Synd NCT00047268 | European Working Group of MDS in Childhood | Phase 3 |
| Unknown | Umbilical Cord Blood and Placental Blood Transplantation in Treating Patients With Hematologic Cancer or Aplas NCT00008164 | Herbert Irving Comprehensive Cancer Center | Phase 2 |
| Terminated | Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer NCT00008216 | Columbia University | — |
| Completed | Donor Bone Marrow Transplant in Treating Patients With Leukemia, Lymphoma, or Nonmalignant Hematologic Disorde NCT00005622 | H. Lee Moffitt Cancer Center and Research Institute | Phase 2 |
| Completed | Interleukin-2 in Treating Patients With Myelodysplastic Syndrome NCT00002746 | University of Washington | Phase 1 |
| Completed | T-cell Depleted Bone Marrow and G-CSF Stimulated Peripheral Stem Cell Transplantation From Related Donors in T NCT00002718 | Memorial Sloan Kettering Cancer Center | Phase 2 |
| Completed | Bone Marrow Transplant in Treating Patients With Hematologic Cancers NCT00005797 | H. Lee Moffitt Cancer Center and Research Institute | Phase 2 |
| Completed | S9007, Study of Bone Marrow and Blood Samples From Patients With Leukemia or Other Hematopoietic Cancers NCT00996047 | SWOG Cancer Research Network | — |
| Completed | Research Study in Healthy Volunteers of Patients With Fanconi Anemia, Myeloproliferative Disorders, or Myeloma NCT00900055 | OHSU Knight Cancer Institute | — |
| Withdrawn | Antimicrobial Solution or Saline Solution in Maintaining Catheter Patency and Preventing Catheter-Related Bloo NCT01101412 | M.D. Anderson Cancer Center | Phase 1 / Phase 2 |